| PERIOD ENDING | 30-Jun-04 | 31-Mar-04 | | Total Revenue | 13,563 | 12,668 | | Cost of Revenue | 6,543 | 6,477 | | | Gross Profit | 7,020 | 6,191 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 4,064 | 4,262 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 2,956 | 1,929 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 77 | 38 | | Earnings Before Interest And Taxes | 3,033 | 1,967 | | Interest Expense |
-
|
-
| | Income Before Tax | 3,033 | 1,967 | | Income Tax Expense | 946 | 913 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 2,087 | 1,054 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 2,087 | 1,054 | | Preferred Stock And Other Adjustments | (681) | (341) | | | Net Income Applicable To Common Shares | $1,406 | $712 |
|
0.11% Nasdaq 0.00%
Income Statement
